0001209191-21-045418.txt : 20210706
0001209191-21-045418.hdr.sgml : 20210706
20210706161202
ACCESSION NUMBER: 0001209191-21-045418
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210630
FILED AS OF DATE: 20210706
DATE AS OF CHANGE: 20210706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KING RICHARD
CENTRAL INDEX KEY: 0001013702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39594
FILM NUMBER: 211074195
MAIL ADDRESS:
STREET 1: C/O KOS PHARMACEUTICALS INC
STREET 2: 1001 BRICKELL AVE 25TH FL
CITY: MIAMI
STATE: FL
ZIP: 33131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001683553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812154263
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 294-1687
MAIL ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-30
0
0001683553
SPRUCE BIOSCIENCES, INC.
SPRB
0001013702
KING RICHARD
2001 JUNIPERO SERRA BOULEVARD, SUITE 640
DALY CITY
CA
94014
1
1
0
0
Chief Executive Officer
Common Stock
2021-06-30
5
J
0
E
2230
9.5285
A
2230
D
Shares acquired by Mr. King pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
/s/ Samir Gharib, Attorney-in-Fact
2021-07-06